Jafron Biomedical Co Ltd (300529) — Long-term Investment Intensity
Jafron Biomedical Co Ltd (300529) has a Long-term Investment Intensity of 3.9% as of September 2019. Long-term investments of CN¥90.57 Million represent 3.9% of total assets of CN¥2.32 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Jafron Biomedical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Jafron Biomedical Co Ltd Long-term Investment Intensity (2018–2018)
This chart shows how Jafron Biomedical Co Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2018 to 2018. As of September 2019, the intensity stands at 3.9%, reflecting long-term investments of CN¥90.57 Million against total assets of CN¥2.32 Billion CNY. Explore 300529 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Jafron Biomedical Co Ltd (2018–2018)
The table below presents the year-by-year Long-term Investment Intensity for Jafron Biomedical Co Ltd from 2018 to 2018, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 300529 market cap.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 4.4% | CN¥90.57 Million | CN¥2.05 Billion | — |